Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Review Article

JCR. 2014; 1(1): 25-28


A REVIEW ON IRBESARTAN CO ADMINISTERED WITH ATORVASTATIN FOR THE TREATMENT OF CARDIAC RISK

PARAS VIRANI, RAJANIT SOJITRA, HASUMATI RAJ, VINEET JAIN.

Abstract
Hypertension and Hypercholesterolemia are a major public health problem in the developed Countries recently. Hypertension and hypercholesterolemia are frequently treated with antihypertensive drugs like calcium-channel blockers, angiotensin-converting enzyme inhibitors, and angiotensinII (AT1) receptor blockers, and statins. Irbesartan is angiotensin II receptor type 1 antagonist and widely used in treatment of hypertension condition. Atorvastatin is HMG CoA reductase inhibitor and widely used in treatment of hyper lipidaemias condition. .Combination of irbesartan and atorvastatin is used in the treatment of cardiovascular diseases like hypertension and hyper lipidemias. So this combination therapy gives antihypertensive and antilipidemic effects in the treatment of coronary artery diseases.

Key words: Irbesartan, Atorvastatin, Antihypertensive, Antilipidemic, Pharmacology, Combination Therapy.


Full-text options

Full-text Article




Advertisement
American Journal of Research in Medical Sciences

SUBMIT YOUR ARTICLE NOW




ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.